Position in INSM
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,908,038
+$3,598,570 QoQ
Shares Held
46,033
+474.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#214
of 663 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 24%
Shared 0%
None 76%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $75,123,826 across 13 Biotechnology names. INSM ranks #5 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,137 | $17,453,602 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
206,563 | $16,167,686 | |
| 3 | EXEL |
Exelixis, Inc.
|
274,867 | $14,955,513 | |
| 4 | INCY |
Incyte Corp
|
113,231 | $12,835,866 | |
| 5 | INSM |
INSMED Inc
This page
|
46,033 | $4,908,038 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,132 | $3,200,007 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
7,097 | $2,136,409 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
25,727 | $2,039,893 |
All Filings in INSM
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,908,038 | 46,033 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $1,309,468 | 8,008 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $5,312,919 | 30,527 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $5,389,430 | 37,424 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $8,564,665 | 85,102 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $111,230 | 1,458 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $2,167,165 | 31,390 | Shares | Defined | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||